In our research evaluating the role of IL-35 expression in antigen-specific tolerance in prostate cancer patients, we identified CD8+CTLA-4+ IL-35-expressing T cells specific for the prostate tumor-associated antigen prostatic acid phosphatase (PAP), which were present in some patients with prostate cancer (23). The gene discussed is CTLA4; the disease is prostate cancer.